Found: 77
Select item for more details and to access through your institution.
ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ESR/ERS statement paper on lung cancer screening.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ESR/ERS white paper on lung cancer screening.
- Published in:
- European Radiology, 2015, v. 25, n. 9, p. 2519, doi. 10.1007/s00330-015-3697-0
- By:
- Publication type:
- Article
Efficacy and Safety of ALK Tyrosine Kinase Inhibitors in Elderly Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer: Findings from the Real-Life Cohort.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 5, p. 275, doi. 10.1159/000499086
- By:
- Publication type:
- Article
Efficacy and Safety of ALK Tyrosine Kinase Inhibitors in Elderly Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer: Findings from the Real-Life Cohort.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 4, p. 275, doi. 10.1159/000499086
- By:
- Publication type:
- Article
Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 2, p. 185, doi. 10.1007/s40261-021-01116-4
- By:
- Publication type:
- Article
Sniffing the Unique 'Odor Print' of Non-Small-Cell Lung Cancer with Gold Nanoparticles.
- Published in:
- Small, 2009, v. 5, n. 22, p. 2618, doi. 10.1002/smll.200900937
- By:
- Publication type:
- Article
High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2023, v. 27, n. 4, p. 217, doi. 10.5114/wo.2023.135246
- By:
- Publication type:
- Article
Volatile Organic Compounds in Exhaled Breath as Biomarkers for the Early Detection and Screening of Lung Cancer.
- Published in:
- Current Medical Literature: Lung Cancer, 2012, v. 5, n. 4, p. 107
- By:
- Publication type:
- Article
Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.625668
- By:
- Publication type:
- Article
BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.603223
- By:
- Publication type:
- Article
Mitochondrial induction as a potential radio-sensitizer in lung cancer cells - a short report.
- Published in:
- Cellular Oncology (2211-3428), 2015, v. 38, n. 3, p. 247, doi. 10.1007/s13402-014-0212-6
- By:
- Publication type:
- Article
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer.
- Published in:
- Cellular Oncology (2211-3428), 2013, v. 36, n. 4, p. 277, doi. 10.1007/s13402-013-0133-9
- By:
- Publication type:
- Article
Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage Therapy.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 309, doi. 10.1159/000510806
- By:
- Publication type:
- Article
Associated Myocarditis: A Predictive Factor for Response?
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 2, p. 550, doi. 10.1159/000507278
- By:
- Publication type:
- Article
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 29, doi. 10.1159/000495980
- By:
- Publication type:
- Article
Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 9, p. 2227, doi. 10.1007/s12094-024-03450-3
- By:
- Publication type:
- Article
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3992, doi. 10.3390/ijms25073992
- By:
- Publication type:
- Article
NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic Drugs.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14054, doi. 10.3390/ijms232214054
- By:
- Publication type:
- Article
Increased Risk for Cancer in Young Patients with Severe Obstructive Sleep Apnea.
- Published in:
- Respiration, 2018, v. 97, n. 1, p. 15, doi. 10.1159/000486577
- By:
- Publication type:
- Article
Association of Elevated Levels of Vascular Endothelial Growth Factor in Obstructive Sleep Apnea Syndrome with Patient Age rather than with Obstructive Sleep Apnea Syndrome Severity.
- Published in:
- Respiration, 2007, v. 74, n. 1, p. 50, doi. 10.1159/000095675
- By:
- Publication type:
- Article
Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00473-x
- By:
- Publication type:
- Article
Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221103206
- By:
- Publication type:
- Article
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059874
- By:
- Publication type:
- Article
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 2, p. 212, doi. 10.1038/s41416-024-02709-4
- By:
- Publication type:
- Article
Short and long-term usage of a dental device in sleep apnea syndrome.
- Published in:
- Laryngoscope, 2009, v. 119, n. 3, p. 585, doi. 10.1002/lary.20103
- By:
- Publication type:
- Article
Protective Effect of Immunosuppression on Granulation Tissue Formation in Metallic Airway Stents.
- Published in:
- Laryngoscope, 2008, v. 118, n. 8, p. 1383, doi. 10.1097/MLG.0b013e318172d686
- By:
- Publication type:
- Article
Circulating Tumor DNA T790M Testing as a Predictor of Osimertinib Efficacy in Epidermal Growth Factor Receptor Mutant Non-small Cell Lung Cancer: A Single Center Experience.
- Published in:
- Israel Medical Association Journal, 2019, v. 21, n. 6, p. 394
- By:
- Publication type:
- Article
Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution Experience.
- Published in:
- Oncology, 2022, v. 100, n. 9, p. 467, doi. 10.1159/000525188
- By:
- Publication type:
- Article
High-Dose Radiotherapy as Neoadjuvant Treatment in Non-Small-Cell Lung Cancer.
- Published in:
- Oncology, 2018, v. 95, n. 1, p. 13, doi. 10.1159/000487928
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Familial Mediterranean Fever and Incidence of Cancer.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 1, p. 127, doi. 10.1002/art.40344
- By:
- Publication type:
- Article
Stereotactic body radiotherapy for central lung tumors, yes we can!
- Published in:
- 2018
- By:
- Publication type:
- journal article
Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome.
- Published in:
- American Journal of Hypertension, 1998, v. 11, n. 11, p. 1284, doi. 10.1016/S0895-7061(98)00159-9
- By:
- Publication type:
- Article
ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data.
- Published in:
- Oncologist, 2022, v. 27, n. 1, p. e76, doi. 10.1093/oncolo/oyab005
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-ResponsiveALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 762, doi. 10.1634/theoncologist.2015-0497
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. e25, doi. 10.1634/theoncologist.2015-0157
- By:
- Publication type:
- Article
Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 316, doi. 10.1634/theoncologist.2014-0389
- By:
- Publication type:
- Article
Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer Screening.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1124949
- By:
- Publication type:
- Article
Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non‐small cell lung cancer: A large real‐world cohort and review of the literature.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1589, doi. 10.1111/1759-7714.14902
- By:
- Publication type:
- Article
Development of Pericardial Effusion in Non-small Cell Lung Cancer Is Associated with the Presence of EGFR/ALK Mutations.
- Published in:
- Israel Medical Association Journal, 2022, v. 24, n. 3, p. 135
- By:
- Publication type:
- Article
Stereotactic Radiosurgery for Brain Metastases in Small Cell Lung Cancer: The Davidoff Cancer Center Experience.
- Published in:
- Israel Medical Association Journal, 2020, v. 22, n. 1, p. 22
- By:
- Publication type:
- Article
Prophylactic Topical Treatment for EGFR Inhibitor-Induced Papulopustular Rash: A Randomized Clinical Trial.
- Published in:
- Dermatology (10188665), 2021, v. 237, n. 6, p. 988, doi. 10.1159/000511869
- By:
- Publication type:
- Article
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059874
- By:
- Publication type:
- Article
Review: Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 137, doi. 10.1177/1758834009347923
- By:
- Publication type:
- Article
Low-dose computed-tomography lung cancer screening : the first European recommendations from the European Society of Radiology and European Respiratory Society.
- Published in:
- Polish Archives of Internal Medicine, 2015, v. 125, n. 9, p. 607, doi. 10.20452/pamw.3029
- By:
- Publication type:
- Article